Insider Buying: NewGenIvf Group (NASDAQ:NIVF) Major Shareholder Acquires $136,165.59 in Stock

NewGenIvf Group Limited (NASDAQ:NIVF) major shareholder Financial Lp Hrt purchased 137,541 shares of the business’s stock in a transaction dated Friday, May 22nd. The shares were acquired at an average cost of $0.99 per share, for a total transaction of $136,165.59. Following the acquisition, the insider owned 111,885 shares of the company’s stock, valued at approximately $110,766.15. The trade was a -536.10% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. Major shareholders that own at least 10% of a company’s shares are required to disclose their transactions with the SEC.

Financial Lp Hrt also recently made the following trade(s):

• On Wednesday, May 27th, Financial Lp Hrt sold 85,317 shares of NewGenIvf Group stock. The shares were sold at an average price of $0.80, for a total value of $68,253.60.
• On Tuesday, May 26th, Financial Lp Hrt bought 27,993 shares of NewGenIvf Group stock. The shares were purchased at an average cost of $0.92 per share, for a total transaction of $25,753.56.

NewGenIvf Group Trading Down 11.7%

Shares of NASDAQ:NIVF opened at $0.91 on Friday. NewGenIvf Group Limited has a 12 month low of $0.72 and a 12 month high of $1,839.00. The stock’s 50 day moving average price is $1.65 and its 200 day moving average price is $6.70. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.12 and a quick ratio of 2.98.

NewGenIvf Group (NASDAQ:NIVF) last announced its earnings results on Tuesday, March 31st. The company reported ($287.24) EPS for the quarter. The company had revenue of $1.42 million during the quarter. As a group, equities research analysts anticipate that NewGenIvf Group Limited will post 4.74 EPS for the current fiscal year.

Analyst Ratings Changes

Separately, Weiss Ratings reissued a “sell (d)” rating on shares of NewGenIvf Group in a report on Monday, April 27th. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, NewGenIvf Group presently has an average rating of “Sell”.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.